Drax stock reacts to analyst upgrades and H1 2026 profit drop

Drax stock (ISIN GB00B1VNSX38) is trading at 790.50 pence on the London Stock Exchange as of September 2, 2026, leaving it clearly below its 52-week high of 937.50 pence but above the 52-week low of 626 pence according to market data compiled by MarketBeat. The same overview shows a market capitalization of about 2.66 billion pounds at this price level, underlining that the utility is valued modestly relative to its 5.22 billion pounds of annual sales.

Analyst upgrades highlight upside potential

According to a Drax-focused article on ad-hoc-news.de dated September 2, 2026, an assessment reported on September 1, 2026, pointed to stronger cash generation and long-term growth potential from renewable energy and data center projects, and cited a new 12-month price target of 1,020 pence versus a previous target of 924 pence, implying an upside of about 31.6% from a prior closing level of 775 pence.

The same ad-hoc-news.de report, summarizing an analysis originally carried on Investing.com, noted that the new target of 1,020 pence compares with the then prevailing share price of 775 pence as of September 1, 2026, which corresponds to a substantial discount versus the analyst’s view of fair value and reflects investor caution around policy risk and biomass cost inflation.

In parallel, an overview of analyst opinions on Drax compiled by MarketBeat indicates that as of September 2, 2026, Drax carries a consensus rating of Moderate Buy based on three published recommendations and an average price target of 3,343.33 pence, suggesting an implied upside of more than 300% from the current price region around 790.50 pence.

H1 2026 results and valuation in focus

Investors are weighing this upside against a softer earnings backdrop: a summary of Drax’s half year 2026 figures on MarketScreener, dated July 30, 2026, reports that profit and revenue declined versus the prior year, with earnings per share for H1 2026 at 48.3 pence compared with a higher level in the previous first half, reflecting lower power prices and ongoing investment in renewable capacity.

Despite this pressure on interim profit, MarketBeat states that Drax generated approximately 5.22 billion pounds in annual sales over its latest reported twelve-month period, and at the current market capitalization of 2.66 billion pounds this corresponds to a price-to-sales ratio of roughly 0.51, which is low for a company with a growing portfolio of regulated and contracted renewable assets.

The same MarketBeat data set as of September 2, 2026, shows trailing earnings per share of 8.50 pence and a trailing price-to-earnings ratio of about 93, indicating that on historical earnings the stock screens expensive, yet the very low price-to-earnings-growth ratio of 0.10 hints that analysts expect a significant increase in profitability over the coming years as new projects ramp up.

Biomass power and pumped storage assets

Drax Group operates a mix of biomass and hydro assets that underpin its growth story, including the large Drax Power Station in Selby, North Yorkshire, which has been largely converted from coal to biomass and provides renewable, dispatchable power to the United Kingdom grid, according to the company profile summarized by MarketBeat as of September 2, 2026.

Beyond the main power station, the same company description highlights that Drax owns the Cruachan pumped storage hydro facility in Scotland with an installed capacity of 440 megawatts and additional Lanark and Galloway hydro-electric stations totaling 126 megawatts, giving the group a significant flexible-generation footprint that is particularly valuable as intermittent wind and solar penetration rises.

Drax stock and current market level

Based on the MarketBeat quote as of September 2, 2026, Drax stock is changing hands at 790.50 pence on the London Stock Exchange, with a 52-week trading range between 626 pence and 937.50 pence and a dividend yield of 3.91%, positioning the shares as an income-generating utility play that still trades well below the consensus analyst price target.